Work

P1.01-83 Comparative Efficacy Analysis Between Entrectinib Trial and Crizotinib Real-World ROS1 Fusion-Positive (ROS1+) NSCLC Patients

Year: 2019

Type: article

Study design: Observational Study

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.798

Authors: R. Doebele, L. Perez, H. Trinh, M. Martinec, R. Martina, T. Riehl, M. Krebs, N. Meropol, W. Wong, G. Crane

Institutions: University of Colorado Denver, F. Hoffmann-La Roche AG, Genentech, University of Liverpool, University of Manchester, The Christie NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, NIHR Manchester Clinical Research Facility, Flatiron Health (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981403738

FWCI: 1.104

Cites:

Cited by: 6

Related to: 10